Navigation Links
Lexicon Pharmaceuticals To Present At The Piper Jaffray Annual Healthcare Conference
Date:11/20/2012

THE WOODLANDS, Texas, Nov. 20, 2012 /PRNewswire/ -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) announced today that Brian Zambrowicz, Ph.D., Executive Vice President and  Chief Scientific Officer, will present at the Piper Jaffray Annual Healthcare Conference on Tuesday, November 27th, at 12:30 p.m. EST in New York City. Dr. Zambrowicz will provide an overview of Lexicon's clinical development programs and milestones.

A webcast of the presentation will be available through Lexicon´s website at www.lexpharma.com. An archived version of the presentation will be available at www.lexpharma.com until December 27th, 2012.

About Lexicon

Lexicon is a biopharmaceutical company focused on discovering breakthrough treatments for human disease.  Lexicon currently has four drug programs in mid-stage development for diabetes, irritable bowel syndrome, carcinoid syndrome and rheumatoid arthritis, all of which were discovered by Lexicon's research team.  Lexicon has used its proprietary gene knockout technology to identify more than 100 promising drug targets.  Lexicon has focused drug discovery efforts on these biologically-validated targets to create its extensive pipeline of clinical and preclinical programs.  For additional information about Lexicon and its programs, please visit www.lexpharma.com.

Safe Harbor Statement

This press release contains "forward-looking statements," including statements relating to Lexicon's growth and future operating results, discovery and development of products, strategic alliances and intellectual property, as well as other matters that are not historical facts or information.  All forward-l
'/>"/>

SOURCE Lexicon Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Lexicon to Provide First Quarter 2012 Financial Results
2. Lexicon Pharmaceuticals Reports On Clinical Program Status And 2012 First Quarter Results
3. Lexicon Receives Funding for Phase 2 Clinical Trial of LX4211 in Type 1 Diabetes
4. Lexicon Pharmaceuticals to present at the Jefferies 2012 Global Healthcare Conference
5. Lexicon Presents Data Regarding the Mechanism of Action and Safety of LX4211 at American Diabetes Association Meeting
6. Lexicon Announces Positive Results of LX4211 Phase 2b Trial For Type 2 Diabetes
7. Lexicon Announces Publication of Results of Two Studies of LX4211 in Patients with Type 2 Diabetes in the Journal Clinical Pharmacology & Therapeutics
8. Lexicon to Provide Second Quarter 2012 Financial Results
9. Lexicon Pharmaceuticals Reports On Clinical Program Status And 2012 Second Quarter Results
10. Lexicon Pharmaceuticals To Present At The Wedbush PacGrow 2012 Management Access Conference
11. Lexicon Pharmaceuticals Reports Preliminary Results From Two Phase 1 Studies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... 2014  Novation, the leading health care supply chain expertise, ... reseller (VAR) national contracts that expand its portfolio to ... lower costs. These include manufacturer product and service agreements, ... and ongoing IT consulting support. New ...
(Date:1/15/2014)... 2014 Shire plc (LSE: SHP, NASDAQ: ... Trading (OFT) approval condition to the announced tender offer for all ... As a result of the waiver, the transaction is no ... tender offer on January 24, 2014 following the currently scheduled expiration ...
(Date:1/15/2014)... , Jan. 15, 2014  Manufacturers, suppliers and distributors ... able to protect their most important business assets, ... ) Because of the highly-competitive ... remains one of the most litigious industry sectors ...
Breaking Medicine Technology:New Novation Information Technology VAR Contracts Offer Significant Savings to Hospitals 2Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 2Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 3Intellectual Property Insurance for Medical-related Products and Services 2
... LAKE FOREST, Ill., Aug. 20 The board of directors ... specialty pharmaceutical and medication delivery company, today announced that Christopher ... his intent to retire from the CEO position after more ... CEO until his successor is named. He will then remain ...
... Aug. 19 A drug to treat inflammation plays a surprising ... that is deadly for AIDS and cancer patients and others with ... to get rid of the fungal evaders by enhancing the body,s ... litter the lungs, where it would continue to provoke an onslaught ...
Cached Medicine Technology:Hospira Announces CEO Succession Plan 2Hospira Announces CEO Succession Plan 3Hospira Announces CEO Succession Plan 4Old Drug Holds Promise Against Opportunistic Lung Bug 2Old Drug Holds Promise Against Opportunistic Lung Bug 3Old Drug Holds Promise Against Opportunistic Lung Bug 4
(Date:4/17/2014)... who treat patients with a severe and progressive ... agonizing treatment decision. , The drug sirolimus can ... shortness of breath. But some patients eventually may ... fatal complications following transplantation. , "It,s a terrible ... of Loyola University Medical Center,s LAM Clinic and ...
(Date:4/17/2014)... 2014) The cause of neuronal death in Parkinson,s ... that neurons may be mistaken for foreign invaders and ... the way autoimmune diseases like type I diabetes, celiac ... study was published April 16, 2014, in Nature ... controversial, idea in Parkinson,s disease; but if true, it ...
(Date:4/17/2014)... Irvine, Calif., April 17, 2014 By discovering a ... immediately after a stroke, researchers at UC Irvine and ... therapies that may limit or prevent stroke-induced brain damage. ... the fourth-leading cause of death and primary reason for ... damaged in a stroke and lets blood-borne material into ...
(Date:4/17/2014)... Alliance, a nonprofit organization that focuses on conservation and ... examining the current state of knowledge of the deadly ... global surveillance strategies to combat the emergence of infectious ... West Africa that has claimed the lives of 122 ... According to the World Health Organization (WHO), the deadly ...
(Date:4/17/2014)... to ward off depression among retirees, particularly among those ... The Journals of Gerontology, Series B: Psychological ... " Internet Use and Depression Among Retired Older Adults ... authors report that Internet use reduced the probability of ... sample. , Late-life depression affects between 5 and ...
Breaking Medicine News(10 mins):Health News:Patients with rare lung disease face agonizing treatment dilemma 2Health News:Patients with rare lung disease face agonizing treatment dilemma 3Health News:Is Parkinson's an autoimmune disease? 2Health News:Study IDs new cause of brain bleeding immediately after stroke 2Health News:Re-emergence of Ebola focuses need for global surveillance strategies 2Health News:Re-emergence of Ebola focuses need for global surveillance strategies 3Health News:Internet use may cut retirees' depression 2
... certain but solutions less so, experts say, , , FRIDAY, April 24 ... hard to avoid. But for people in stressful jobs, it,s especially ... protect the heart. , That,s because stress not only has ... but also a second. , "Work stress is bad for ...
... Hope Considered ,Too Important Not To Be Heard,SAN MATEO, ... that "Light of Hope: Help for Children with Autism," ... debut internationally on Friday, April 24, Saturday, April 25 ... during the final week of World Autism Awareness ...
... 2009 Annual Meeting of ShareholdersMCKINNEY, Texas, April 24 TORCHMARK CORPORATION (NYSE: ... 2009 Annual Meeting of Shareholders, When: ... Where: http://www.videonewswire.com/event.asp?id=56940 , How: ... at the, ...
... 24 Pharmatech Oncology, Inc., a Research Management ... launch of their Data Management business unit to ... Oncology Data Management business unit is branded as ... Data Management business unit maintains and processes data ...
... Copenhagen, Denmark, Friday 24 April: HIV positive and ... transplant, according to new research presented today at EASL ... the Study of Liver in Copenhagen, Denmark. , The ... 1 and 5 years between HIV negative and HIV ...
... HealthYes!™ is bringing its life-saving mobile screening services to ... most medically-advanced, state-of-the-art equipment and techniques to screen its ... abdominal aortic aneurysm, osteoporosis, and peripheral artery disease. ... ...
Cached Medicine News:Health News:Work Strife Stresses the Heart 2Health News:Work Strife Stresses the Heart 3Health News:'Light of Hope: Help for Children with Autism' Ground-Breaking Internet Television Event on April 24 to April 26 Co-Sponsored by Internet Software Leaders 2Health News:'Light of Hope: Help for Children with Autism' Ground-Breaking Internet Television Event on April 24 to April 26 Co-Sponsored by Internet Software Leaders 3Health News:Pharmatech Oncology Launches New Data Management Business Unit 2Health News:HIV positive and HIV negative patients have similar survival rates following liver transplant 2Health News:Texas-Based Mobile Health Screening Company Expands into Dallas-Fort Worth 2Health News:Texas-Based Mobile Health Screening Company Expands into Dallas-Fort Worth 3
... accurate one tube system for screening of ... EnteroScreen 4™ is specifically designed to rule ... in the detection and the differentiation of ... Lysine Iron Agar, Lysine Iron Agar (LIA), ...
... software product enabling quick and easy storage ... With SpecTRACK Software, users can find the ... all laboratories in their LAN network, eliminating ... room. Automate your existing manual sample storage ...
... contact lenses designed to address two common ... presbyopia and eye dryness. , Only Proclear ... Balanced Progressive Technology, with a unique lens ... The result? Lenses that give you great ...
... a smooth, flat tip extending from the ... uniquely designed tip is used to efficiently ... the posterior capsule. The end opening ... sideports help avoid surge should the end ...
Medicine Products: